ADAkash Deep

Akash Deep

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Akash Deep has a total of 221 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Immediate vs delayed extubation after pediatric liver transplantation: a systematic review and meta-analysis

    by Marco Daverio, Goda Laucaityte, Matthew A. Goldstein, Giacomo Berti, Yonca Bulut, Akash Deep, Mihaela Damian, Rujipat Samransamruajkit, Gerard Cortina, Serge Grazioli, et al.

  • Open Access

    When to start continuous kidney replacement therapy in critically ill children: a practical, PICU-focused, evidence-based review

    by Gerard Cortina, Akash Deep

    Acute kidney injury (AKI) and fluid overload (FO) are common in critically ill children and have been shown to be associated with adverse outcomes. Continuous kidney replacement therapy (CKRT) is the preferred renal support modality in paediatric intensive care to treat children with AKI and FO and may be necessary for non-renal indications like life-threatening toxin or electrolyte removal. However, the timing of CKRT initiation remains a contentious and highly variable clinical decision. Classic indications for dialysis are well established, yet modern paediatric intensive care practice increasingly emphasises earlier intervention for FO and evolving multi-organ dysfunction. Adult randomised trials have not demonstrated a survival benefit for early CKRT based on biochemical thresholds alone, mainly AKI stage. However, their applicability to paediatric populations is limited by distinct disease biology, developmental physiology, and fluid tolerance. This review synthesises current evidence and expert guidance to provide a pragmatic, physiology-driven framework for CKRT initiation in critically ill children. Emphasis is placed on dynamic assessment of kidney trajectory, fluid balance, and extra-renal organ impact rather than fixed biochemical thresholds or rigid timing paradigms. Integration of these factors balances the relative benefits and risks of early CKRT initiation and facilitates timely and individualised decisions that optimise outcomes in this vulnerable population. Graphical Abstract A higher resolution version of the Graphical Abstract is available as Supplementary information.

  • Outcomes of Acute Kidney Injury in Pediatric Liver Transplant: Retrospective Cohort Study, 2013–2023

    by Raman Singla, Subramanyam Sheshadri, Emma C. Alexander, Anish Gupta, Farah Tasneem, Katyayani Katyayani, Pádraig Ó. Scanaill, Richard Lin, Gaurang Upadhyay, Akash Deep

    OBJECTIVES: We aimed to determine the prevalence of acute kidney injury (AKI) after pediatric liver transplantation (LT) and the associated preoperative and intraoperative factors. DESIGN: Single-center retrospective cohort study. SETTING: Sixteen-bed PICU in a university-affiliated tertiary care hospital. PATIENTS: PICU admissions with liver disease who underwent LT between January 2013 and December 2023. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We analyzed data from the first week, 90 days, and at 1-year follow-up. Patients with stage 2–3 AKI according to the Kidney Disease: Improving Global Outcomes (KDIGO) definitions or those receiving continuous renal replacement therapy for renal or mixed hepatorenal indications were defined as having severe AKI. There were 283 children with liver disease who underwent LT. Over the first postoperative week, 64.7% (183/283) developed AKI, including 30.4% (86/283) with severe AKI. Peak AKI occurred within the first 24 hours after surgery in 50.2% of LT patients (142/283). In a multivariable logistic regression model, pretransplant bilirubin levels, baseline renal function, and longer operative duration were associated with severe AKI. Severe AKI was associated with prolonged mechanical ventilation, longer PICU and hospital stays, and greater mortality in posttransplant patients. At 90-day follow-up, 1.9% of patients (5/260) had an estimated glomerular filtration rate less than 60 mL/min/1.73 m 2 . CONCLUSIONS: In our 2013–2023 retrospective cohort, a high proportion of children developed severe AKI within 1 week of LT. Preoperative factors such as bilirubin level, renal function, and intraoperative factors like procedure duration were associated with severe AKI. Severe AKI was associated with prolonged mechanical ventilation, length of PICU and hospital stay, and greater mortality. Further studies are needed to explore risk models.

  • Open Access

    Terlipressin in paediatric hepatorenal syndrome-acute kidney injury (HRS-AKI)

    by Emma C. Alexander, Benjamin Wyness, Kevin Moore, Francisco Flores, Akash Deep

    Children with chronic liver disease are at increased risk of acute kidney injury (AKI), which could be non-hepatorenal syndrome AKI (non-HRS-AKI) or hepatorenal syndrome AKI (HRS-AKI). Approximately 5–10% of these children develop HRS-AKI. In this cohort, portal hypertension leads to splanchnic vasodilatation, reduced mean arterial pressure, and compensatory renal arteriolar vasoconstriction. The reduction of mean arterial pressure and renal vasoconstriction reduces renal perfusion, causing functional renal failure and AKI (acute kidney injury). HRS-AKI may be precipitated by sepsis or inflammation, which may impact cardiac function in patients with cirrhotic cardiomyopathy. While liver transplantation remains curative, adult randomised controlled trials have demonstrated that treatment with terlipressin can potentially reverse HRS-AKI. Limited paediatric studies also suggest terlipressin may also be effective in children, though effects on mortality remain unexplored. In this review, we explore the prevalence and pathophysiology of HRS-AKI in paediatric liver disease, summarise evidence from adult trials supporting terlipressin use, highlight cautions and contraindications associated with its use in adults and children, and propose principles for its safe prescription. Additionally, we outline future research priorities, including the potential role of renal biomarkers in managing this high-risk population. Graphical Abstract

  • Open Access

    Utility of transcranial Doppler and reversed jugular venous saturations for neuromonitoring in children with acute liver failure

    by Raman Singla, Emma C. Alexander, Pervez Khan, Ben Freedman, Rehab Elseidy, Subramanyam Sheshadri, Bogdana Zoica, Akash Deep

    Paediatric Acute Liver Failure (PALF) is associated with high morbidity and mortality, with cerebral oedema a key contributor to mortality. The aim of our study was to examine the association between the findings of two neuromonitoring modalities (transcranial Doppler (TCD) and reverse venous jugular oxygen saturation (SjvO 2 ) and mortality, as well as ammonia levels, in children with acute liver failure who received neuroprotection within 7 days of paediatric intensive care unit (PICU) admission. Retrospective observational cohort study. Sixteen-bed PICU in a UK university-affiliated tertiary care hospital. Patients admitted to the PICU with PALF were reviewed between January 2013 and October 2023. Seventy-eight children, who were intubated and ventilated, had neuromonitoring either with TCD/SjvO 2 or both during the first week of hospital admission (before liver transplantation), and were included in the study. Interventions: None. The median (IQR) age of the study population was 64 (25–144) months. Among the 78 children, 24 (30.8%) survived without liver transplant, 39 children (50.0%) survived post-liver transplant, 5 (6.4%) died post-transplant, and 10 (12.8%) died without transplant. Patients who died had a lower meanvelocity in the right middle cerebral artery (RMCA Vm) (Median: 34 cm/s vs 55 cm/s, p -value: 0.01) and higher pulsatility index (PI) than those who survived (Median: 2.1 vs 1.6, p : 0.001). SjvO 2 was also lower in non-survivors than in survivors (Mean: 39.0% vs 56.1%, p -value: 0.002). The PI had a weak positive correlation with ammonia (Rho: 0.25, p : 0.005). RMCA Vm and SjvO 2 had a negative correlation with ammonia (Rho: − 0.21, p -value: 0.022; Rho − 0.22; p -value: 0.017 respectively). Conclusion : Patients with acute liver failure who died had a high RMCA PI, lower RMCA Vm, and lower SjvO 2 . TCD and SjvO 2 may serve as useful adjuncts to the overall neurological assessment in critically ill children with PALF. What is Known: • Paediatric Acute Liver Failure (PALF) is associated with high morbidity and mortality, with cerebral oedema a key contributor to mortality. • There is little published evidence regarding the use of bedside neuromonitoring techniques like transcranial dopplers and reverse jugular saturations in the paediatric population with acute liver failure. What is New: • In our single-centre experience (2013–2023), neuromonitoring in PALF patients correlates with mortality. Bedside neuromonitoring with TCD and SjvO2 showed a weak correlation with ammonia and between each other. • Future work should focus on the impact of neuromonitoring on delivered neuroprotective strategies and patient outcomes.


  • Open Access

    Reframing pediatric hypertension: early life clues and clinical imperatives

    by Akash Deep, Emma C. Alexander

  • Open Access

    Interpreting liver function markers in children on continuous renal replacement therapy for acute liver failure

    by Wun Fung Hui, Akash Deep

    Children with acute liver failure (ALF) often experience hyperammonaemia, fluid overload, metabolic derangements, and multi-organ failure. Continuous renal replacement therapy (CRRT) is commonly used for renal and non-renal indications, particularly in those with hyperammonaemia and hepatic encephalopathy. However, the non-selective nature of CRRT can result in the clearance of beneficial metabolites and liver-related biomarkers, which are important for monitoring disease progression or improvement. Therefore, understanding the kinetic principles governing molecular clearance during CRRT is crucial for accurate interpretation of liver biochemistry to inform clinical decision-making. By considering the kinetic properties of hepatic markers, including bilirubin, bile acids, liver enzymes, metabolites, waste products, inflammatory markers, albumin, and coagulation proteins, we describe the impact of CRRT on the plasma levels of these markers. In addition, we discuss various CRRT attributes, and the removal of these markers is also discussed. Metabolites and waste products, including ammonia, lactate, and urea, are the most useful markers to inform CRRT responsiveness, owing to their small molecular size, low degree of protein binding, and small volume of distribution; whereas bilirubin, bile acids, coagulation factors, and albumin remain true indicators of hepatic function and clinical condition. It should be noted that the overall plasma levels of any molecules reflect the balance between production and clearance, even for molecules with a high degree of CRRT removal. Awareness of these properties helps clinicians differentiate dialytic response versus genuine hepatic recovery or deterioration, guiding a more rational interpretation of clinical progression in ALF with liver transplant/spontaneous native recovery or mortality as the outcomes. Conclusion : Understanding the kinetic behaviour of liver-related markers during CRRT is essential to distinguish between dialytic clearance and true changes in hepatic function. This knowledge enables more accurate clinical interpretation, guiding decision-making in children with acute liver failure and optimizing management strategies toward recovery or timely transplantation. What is Known: • Children with acute liver failure often require CRRT for non-renal causes, including metabolic derangements, hyperammonemia, and multi-organ support. • CRRT non-selectively clears both toxic metabolites and liver-related biomarkers, complicating the interpretation of hepatic function. What is New: • Accounting for the kinetic properties of liver markers during CRRT allows clinicians to distinguish dialytic clearance from true hepatic recovery or deterioration. • Small molecules (ammonia, lactate, urea) might reflect CRRT responsiveness, whereas bilirubin, bile acids, albumin, and coagulation factors indicate liver function and clinical status.